New Weapon Against Cancer FRIDAY, April 18 (HealthScoutNews) -- An experimental drug that triggers the release of nitric oxide to fight leukemia and tumors has been developed by researchers at the University of Utah and the U.S. National Cancer Institute. The drug, JS-K, reacts with a substance inside cancer cells. This reaction causes the release of nitric oxide, which kills or slows the growth of cancer cells without harming healthy cells. Tests with the drug showed it triggered this destruction in acute myeloid leukemia (AML) cells grown in the laboratory. It also slowed the growth of AML cells in mice. AML is the most common and deadly form of leukemia. In other tests on cell cultures, JS-K inhibited growth of AML cells and did the same, to a lesser extent, in prostate, colon and breast cancer cells. It also inhibited the growth of prostate cancer cells in mice. The study appears in the April issue of Molecular Cancer Therapeutics. Thanks to [04/21/2003; HealthSCOUT] and breastcancer.net Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.